Latest News and Press Releases
Want to stay updated on the latest news?
-
STOCKHOLM, SVERIGE 22 juli 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Promimic tillsammans med Danco Medical bildar ett samriskbolag, joint venture, för...
-
STOCKHOLM, SWEDEN, July 22 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic and the US-based company Danco Medical form a joint venture for...
-
STOCKHOLM, SVERIGE 4 juli 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) har fullföljt en tidigare aviserad investering i PharmNovo och inkluderar därmed bolaget bland sina portföljbolag....
-
STOCKHOLM, SWEDEN, July 4, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) has completed a previously announced investment in PharmNovo, thereby including it among its portfolio companies. As...
-
STOCKHOLM, SVERIGE 27 juni 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Svenska Vaccinfabriken har presenterat prekliniska studiedata som indikerar att...
-
STOCKHOLM, Sweden, June 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Svenska Vaccinfabriken has presented results from a preclinical study...
-
STOCKHOLM, SVERIGE 23 juni 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Promimic har presenterat prekliniska resultat som visar att ytbehandlingstekniken...
-
STOCKHOLM, Sweden, June 23, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Promimic today presented preclinical results tshowing that the company’s...
-
STOCKHOLM, SVERIGE 3 juni 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att bolaget ingått avtal om att investera 20 miljoner kronor i PharmNovo AB som utvecklar en helt ny...
-
STOCKHOLM, SWEDEN, June 3, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the company has agreed to invest SEK 20 million in PharmNovo AB, which is developing a novel drug for...